Autopsy report · NCT01371110

Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder

“no funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 3 years before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 2 years 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Wayne Goodman MD

Sponsor type

University, hospital or other

Conditions

Obsessive Compulsive Disorder

Interventions

Ketamine; Midazolam

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Prehabilitation in Patients on a Waiting List for a Transplant
  “No funded” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.